|
|
Other links at Articles > Cardiology |
| 2. |
Risk Factors Identified for Sudden Death in Myotonic Dystrophy Type 1
|
|
|
A 10-year study of adult patients with myotonic dystrophy type 1 confirms their high risk for arrhythmias and sudden death, and identifies factors that appear to predict high risk: patients with severe abnormalities on ECG and atrial tachyarrhythmias had a 3.5- and 5-fold increased risk respectively. Medscape Medical News
|
| 3. |
FDA Recommends Withdrawal of Midodrine
|
|
|
The FDA is recommending the withdrawal of midodrine hydrochloride, currently used in the treatment of hypotension, because there are insufficient data to support its benefit. Heartwire
|
| 4. |
FDA Safety Changes: Levaquin, Lipitor, MDP Kits
|
|
|
The FDA has approved revisions to the safety labeling for levofloxacin tablets, oral solution, and intravenous injection; atorvastatin calcium tablets; and technetium Tc99m medronate injection. Medscape Medical News
|
|
|